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                                        ABSTRACT 
PERIODICAL ASSESSMENT OF PATIENT RELATED 
FACTORS AND  SETUP ERRORS THAT AID  IN 
REPLANNING IN HEAD AND NECK CANCERS 
A PROSPECTIVE STUDY 
                                   Dr.Priyadharsini.D.K, Cancer Institute (WIA) 
 
Aim:To analyse the effect of body mass factors before radiotherapy and changes 
occurring on course of radiation leading to setup error in patient with head and 
neck cancers and need of replanning.  
Materials and methods: This is the prospective study and clinical data of 50 
patients with oropharynx, hypopharynx, nasopharynx cancer was analyzed using 
daily on-line 2D KV image. BMFs included weight, height, circumference and 
thickness of  neck. Alterations in the Body mass factors during treatment were 
recollected from CBCT at  10th and 20th fractions. Repeat CT for RT planning 
done at 40 Gy for all patients.The initial CT and replan CT were registered and the 
structures contoured in initial CT were copied to replan CT to analyze the dose 
volume effect and NTCP if no Re CT and replan was done. Using BMFs the effect 
of the factors on  magnitude of displacement was statistically analyzed. 
Results: Higher body weight before radiotherapy was asscociated with  greater 
setup errors. Among the ratios of the body mass factors during radiotherapy, the 
measures at the level of mastoid tip at 20th fraction were associated with more 
setup error. TCP was significantly better and NTCP was significantly reduced. 
Conclusion: For the patients who have large reduction ratio in circumference (<1) 
and thickness (<0.94)  at the level of mastoid tip at 20 th fraction we should 
consider adaptive radiotherapy  which  improves  TCP and decreases NTCP. 
Key words:Body mass factors, setup errors, adaptive radiotherapy. 
                            
 
 
 
 
  I.INTRODUCTION 
Radiation therapy concomitantly with chemotherapy is a choice of multi-modality 
treatment for head and neck cancer. Intensity modulated radiation therapy (IMRT) 
has become common now a days because we can achieve target dose with sparing 
of normal tissues. But we should be careful in patients’ setup accuracy as IMRT 
causes steep dose gradients. In head and neck cancers correct fitting of the 
immobilization device, change in body contours, and treatment-induced changes 
such as tumor regression and cell death, tumor growth resulting from accelerated 
repopulation, weight loss due to emaciation or weight gain because of changes in 
appetite caused by radiation, concomitant chemotherapy, normal tissue fibrosis, all 
lead to setup abnormalities during course of radiation. Causes might be 
independent or related to the others. Insufficient compensation for these 
uncertainties leads to target under dosing and overdosing of nearby OARs, whereas 
overcompensation for uncertainties leads to unnecessary irradiation of normal 
tissue and constraints in treatment planning. This creates a tradeoff  between tumor 
control probability (TCP) and normal tissue complication probability (NTCP) and 
emphasizes the role of minimizing uncertainties to enhance the therapeutic ratio of 
radiation.Daily Online image guidance  helps in correcting these setup 
uncertainitiesBut IGRT is not always feasible .For patients with anatomic changes 
due to tumor shrinkage or weight loss adaptive radiotherapy is considered. But 
increased costs, higher staff workload, and higher radiation doses to the patients 
should also be considered. So still we have to evaluate the need  of suitable 
indications  for  adaptive radiotherapy in head and neck cancers. 
Radiation therapy (RT) is thel use of ionizing radiation as a part of cancer 
treatment to control tumor cells. Etymology: In Latin radiare means to emit rays; 
and in Greek therapeia means treatment. Thus Radiation is the treatment of 
malignancy  by using ionizing radiation to deter the proliferation of malignant 
cells. The origin of radiotherapy followed on from three major scientific 
discoveries late in the 19th century: the discovery first of x-ray by the famous 
German physicist, Wilhelm Conrad Roentgen in 1895, then  radioactivity by Henry 
Becquerel in 1896 and Radium by Madame Curie in 1898. 
 
 Radiation varies in types and mode of delivery also differs.. The various 
types of ionizing radiation used in radiotherapy are X-radiation, gamma radiation, 
electrons, protons and neutrons, of which gamma rays and high energy X-rays are 
in common practice. Iomisation is the process by which cancer cells are killed.. 
Direct action of radiation kills cancer cells immediately but indirect action is the 
predominant one. Eventhough radiation kills both cancer cells and normal tissues 
most of the normal tissues will recover from effect of radiation. 
 
BASIC PRINCIPLE OF RADIOTHERAPY 
 
Radiotherapy aims to deliver uniform dose distribution to the target volume 
which includes the tumor (GTV), sub-clinical spread of tumor cells (CTV) and 
margin to account for patient movement (PTV), organ movement and day-to-day 
variations in patient set-up. Hence we should keep radiation dose to normal tissues 
to low as possible. Hence more efforts should be done to deliver more accurate 
dose to target volume. 
Conventional External Beam Radiotherapy: 
Conventional EBRT  is delivered by beams of square or rectangular shape. This 
technique is well established and is generally quick and reliable. The limitation is 
the escalation of dose to tumor is limited due to the tolerance limit of the nearby 
critical organs. 
                conventional RT showing rectangular beam shaping 
Three Dimensional Conformal Radiation Therapy: 
Three dimensional conformal therapy (3D CRT), is based on 3D anatomic 
information and use dose distribution that conforms dose to the  target volume  to t 
and  to keep minimum possible dose to normal tissue. The beams are shaped with 
Multi Leaf Collimator controlled by computer system. The irregular shaped fields 
provide better avoidance of normal tissue. 
                                                       MLC 
                                                
 The main distinction between treatment planning of 3D CRT and that of 
conventional radiation therapy is that the former requires the availability of 3D 
anatomic information and a treatment planning system. The important milestone 
which sparked in a revolution in not only radiological diagnosis but also in 
radiotherapy was the invention of x-ray CT. CT was introduced to the radiptherapy 
process at the end of 1970’s and this resulted in 3D treatment planning, now a 
standard tool in radiotherapy. The anatomic information is  obtained in the form of 
closely spaced transverse images, which is  processed to reconstruct anatomy in 
any plane,and in three dimensions. Depending on the modality which we image  
critical structures and visible tumors are outlined slice by slice using planner. 
Limitations of 3D CRT: 
Traditional radiation t techniques, including 3D CRT,  not provides a method for 
sparing critical structures that push into and are partially or fully surrounded by a 
target. To overcome this problem new treatment methods are introduced in 
external radiotherapy.  The intensity modulated radiotherapy provided more 
conformality than any other technique. 
 
1) INTENSITY MODULATED RADIATION THERAPY (IMRT): 
      The first clinical IMRT treatment delivery was in 1994 with serial tomotherapy 
device and then MLC-based IMRT, which was first implemented into clinical use 
at Memorial Sloan-Kettering Cancer Center in 1995. 
 The IMRT technique is most advanced forms of conformal treatment which 
improves Tumor control probability and decreases normal tissue complication 
probability. It is based on inverse treatment planning for determination of the 
required intensity modulated beams and on 3-D multi-modality imaging to define 
the target volumes. Focusing a higher radiation dose to tumor while minimizing 
radiation exposure to surrounding normal tissues is possible using IMRT. IMRT 
also has the potential to reduce treatment toxicity, though doses are not escalated.  
Manipulation of intensities of individual beamlets within each beam is the most 
important advantage of IMRT thereby enabling customized dose distributions. In 
particular, IMRT provides better normal tissue sparing by its ability to produce non 
uniform fluence and hence can generate concave shaped dose distributions. Beam 
comprising a combination of deliberately modified intensities form an intensity 
modulated beam (IMB) and treatment delivered by such a beam is called intensity 
modulated radiotherapy (IMRT). 
                             
                                    
CONCEPT OF INTENSITY MODULATION 
Basic Modes: 
IMRT treatments is delivered with the MLC operating in one of two s modes:  
                    1. The segmented MLC –Step and shoot method.                      
                    2. The dynamic MLC (DMLC) mode,-Sliding window technique  
 
                  In step and shoot method the intensity modulated fields are delivered with 
a sequence of small segments or subfields, each subfield with a uniform intensity. 
The beam is turned on only when leaves are stationary in each given subfield 
position. 
 
                 In the dynamic MLC mode -Sliding window technique the  intensity 
modulated fields are delivered in a dynamic fashion with the leaves of  the MLC 
moving during the irradiation of the patient.  
1. First we have to do treatment planning and delineate target and normal 
structures. 
2. Then we have to do Image guidance and treatment verification using electronic 
portal imaging device which corrects using matching of bony anatomy and 
reference markers.  
 
3. PET Scan and CT scan are used during follow up for assessment of tumor 
response using geometric calculation. 
 
IMAGE MODALITIES AVAILABLE: 
1. KV X-Ray imaging using OBI 
2. MV imaging using EPID. 
3. Fan beam CT 
4. MV CBCT-Used for image guided application on conventional accelerators. 
5. KV CBCT-It is used for bony anatomy. 
6. MRI-Fused with CT. 
7. PET-Mainly used for lung cancers, also used in nasopharyngeal cancers. 
8. US-has only limited accuracy. 
9. SPECT. 
                         
                       DIGITALLY RECONSTRUCTED IMAGE 
                                 
 
SIMULATOR: 
       1. Reference KV image in planned treatment position. 
       2. For comparing pretreatment verification the reference image should be  
 compared with planned image. 
CT SIMULATOR AND VIRTUAL SIMULATION SOFTWARE: 
        1. It is used for virtual simulation procedure. 
        2. For geometric verification digitally reconstructed images are used. 
 
TPS: 
         1. For Importing CT/MRI/PET CT data for planning treatment. 
         2. Image for geometric verification is image of CT simulator. 
ELECTRONIC PORTAL IMAGING DEVICE: 
1. They are taken during treatment delivery using MV treatment beam. 
FILM: 
       1. They are traditional radiographic medium taken during treatment delivery 
using MV beam used for treatment. 
        2. Similar to diagnostic radiology a fiml cassetee loaded with radiochromic 
film is placed in the beam exit of the patient. 
COMPUTED RADIOGRAPHY: 
          1. The plate which is insensitive to ambient light and reusable is place inside 
a traditional cassette. 
          2. Digital radiographs are made by reading the photographic plates in a 
special reader. 
IMPLANTED MARKERS: 
1. Fiducial markers of bio-compatible elements like gold seeds or gold wire 
coils are placed inside the target volume, preferably in soft tissues 
2. They are seen in portal images taken with film and EPIDs.   
 
IN ROOM ULTRASOUND: 
           1. Used for visualizing soft tissue 
           2. Real time positioning of the target volume can be carried out using 
ultrasound imaging on the treatment couch prior to treatment. 
IN ROOM KV IMAGING: 
1. Floor and ceiling mounted diagnostic X ray tubes and image intensifiers 
to give orthogonal images. 
2. Both static and dynamic images are taken to verify patient setup before 
and after treatment delivery and necessary adaptations can be done in the 
treatment plans on an on-line basis. 
INROOM CT IMAGING: 
       1. The CT-On rails is advanced technique where a common couch is shared 
 between the treating LINAC and the CT machine and the CT machine 
 moves through the couch to acquire CT images just prior to treatment 
 execution. 
KV CBCT: 
1. An advanced amorphous silicon detector and a KV X-source are attached to 
the gantry of the treatment machine such that the KV and MV beams are 
orthogonal to each other. 
2. CBCT of the entire volume of the region of interest of treatment shall be 
scanned and a half-beam scan or a full beam scan can be used depending on 
the diameter of the volume to be imaged. 
MV CBCT: 
     1. Megavoltage therapy X beam itself or a dedicated 1MV X beam can be used 
 to take CBCT images using the EPID attached to the treatment gantry. 
3. Since the isocenter is same for both imaging and treatment, an entire 
volume of interest shall be imaged with single setup with much ease. 
CONE BEAM SIMULATOR: 
    1. This is identical to the treatment machine. 
    2. Cheaper solution and a substitute for relatively costlier KV fan beam CT 
 simulation where the image resolution is inferior to fan beam CT as the 
 slices are reconstructed from the volume image information obtained. 
TOMOTHERAPY: 
1. Tomotherapy incorporates the technology used in fan beam CT machines and 
hence getting the advantage of n number of rotations without the limitations 
as we have in other modern LINACS. 
2. This is achieved by replacing a KV source with a MV source to rotate around 
the couch which moves in during beam ON to provide speedy delivery of 
treatment and the binary MLCs takes care of the modulation required to 
provide the intensity modulation. 
 
SURFACE AND MARKER TRACING: 
1. It measures optically the position of markers placed superficially on the 
patients’ skin relative to reference a point. 
   2. Light of optical or infrared wavelength used. 
   3. This is performed continuously throughout the treatment delivery and setup 
 and no radiation exposure associated with this. 
MR LINAC/MR COBALT SOURCE: 
1. Uses very high quality soft tissue imaging principle of magnetic resonance 
and used for image guidance during delivery of treatment. 
 
GATING: 
    1. It is a method of assessing respiration during treatment delivery. 
2. By Tracking the movement of external surrogates during course of treatment   
which indicates when target volume is centered on treatment isocentre. 
3. A relation between external surrogate marker (usually a six dot IR reflector) 
and the movement of internal organs were established. 
 
2) ADAPTIVE RADIOTHERAPY: 
   For a range of clinical radiotherapy cases, the treatment plans optimized based on 
the initial set of computed tomography (CT) images become suboptimal for 
subsequent irradiations due to deformations of the relevant structures. The central 
idea behind Adaptive Radiotherapy (ART) is that adaptation of a treatment plan 
over the entire course of radiation treatment can, result in better therapeutic ratios 
than those that would have resulted from delivery of the initial single treatment 
plan. In routine practice, treatment plans are done with single CT image set 
acquired prior to the treatment course and that plan is usually evaluated using 
DVHs. DVHs based on a single scan may incorrectly estimate the delivered dose. 
Typically in response to weight loss or other “significant” morphological changes, 
plans are adapted for patients. 
Adaptive radiotherapy is being practiced around the world in various forms. Re-
Plan based on Re-CT after therapeutic dose of at least 40Gy is one of the most 
common techniques of ART being practiced. 
 For sites involving intra-fractional movements of the organs at risk and the target 
itself, such as esophagus, a four-dimensional CT is acquired and it is binned into a 
nominal 10 phase CT series. Plans for each phase are generated in the treatment 
planning systems and based on the CTV position on a particular day of treatment 
which is obtained from CBCT acquired prior to the treatment delivery the 
corresponding best suited phase treatment plan is treated. 
In pelvic site tumors such as cervix and prostate, the rectal and bladder fillings 
make a significant change in the target positions and this can be assessed based on 
the daily CBCT acquired prior to the treatment and necessary changes in plan 
chosen for delivery or repositioning the patient. 
ART and image guided radiotherapy has become interlinked and hence modern 
radiotherapy delivery machines with advanced imaging technologies are widely 
preferred to deliver a better clinical results in patients. 
  
 
3) AN OVERVIEW OF SETUP ERRORS: 
GEOMETRIC UNCERTAINITIES IN RADIOTHERAPY: 
DELINEATION ERRORS 
Misplacement in delineated contour with respect to tumor. Error in target volume 
delineation may be the single largest error in the whole radiotherapy chain in 
modern radiotherapy protocols. 
PLANNING ERRORS 
     These errors are caused by wrong beam set up and wrong margins to the CTVs 
and GTVs due to uncertainties in the contouring process using single modality 
images. By proper quality assurance and regular verification of plans by physicists 
may help in eliminating these such errors. 
 
ORGAN MOTION: 
                        This error is mainly due to the movement of tumor with respect to 
bony landmarks. It occurs either during treatment planning or treatment execution. 
 
SETUP ERRORS: 
A shift in the isocentric position when an image is compared against its 
corresponding reference i.e., the calculated deviation between actual and expected 
position is known as set-up error. To maintain correct direction information on 
shifts, vector calculations are done and shifts in anterior directions are given 
positive sign whereas shifts in posterior directions are negative sign. Types of 
setup errors 1.Gross error 2.Systematic error 3.Random error 
Gross error is defined as an unacceptably large set-up error that could underdose 
part of the clinical target volume (CTV) or overdose an organ at risk. As the CTV 
to PTV treatment margins do not account for errors of such magnitude, gross errors 
need to be corrected earlier to the commencement of treatment. 
Systematic error is defined as the error which occurs for each fraction throughout 
the treatment in same direction and similar magnitude. 
Possible cases of gross errors are  
                  1.Incorrect patient. 
                  2,Incorrect patient orientation. 
                  3.Incorrect anatomical site. 
                  4.Incorrect field size. 
                  5.Incorect field shape. 
                  6.Incorrect isocenter position of unacceptable magnitude. 
The preferred method to correct gross error is to image on the first treatment 
fraction immediate to treatment delivery. 
In general, a 10mm error is taken as the level for action in a wide range of sites. 
 SYSTEMATIC ERROR: 
                     It is the deviation that occurs in same direction and is of similar 
magnitude for each fraction throughout the treatment course. 
It is classified into individual and population systematic error. 
 
INDIVIDUAL SYSTEMATIC ERROR: 
                    The systematic error of the individual Patient is the mean error over 
the course of treatment. 
POPULATION SYSTEMATIC ERROR: 
                    It is the systematic error for the group of patients. 
                    It is calculated as the standard deviation of mean errors for each 
patient. 
Causes of systematic error may be: 
1. Target delineation error: the difference between ideal CTV and the 
delineated CTV is considered as target delineation error 
 
2. Target position and shape: when the position of target contoured 
and planned differs from that of the shape and position during 
treatment. 
   
3. Phantom transfer error: 
It is accumulated when transferring image data from initial localization through 
TPS to the linear accelerator. 
They are classified as systematic because causes of phantom transfer do not change 
and it varies slowly (isocentre position and leaf accuracy positions). 
The causes includes differences in 
                  1.Laser alignment between CT and linear accelerator. 
                  2.CT couch longitudinal positional indication. 
                  3.image resolution. 
                  4.margin growing algorithm. 
                  5.Field edge and MLC leaf position. 
                  6.isocentre location. 
                  7.source to surface distance indication. 
                  8.gantry and collimator angle accuracy. 
 
They are corrected by  quality assurance by adequate routine check outs.We should 
ensure that any differences lie within +/-2mm for a distance +/- 1 degree for angle 
indication. 
 
Patient setup error: 
   Causes include: 
                    1.change in patient position. 
                    2.change in shape or size(eg..weight change,hair loss) 
                    3.Movement  of target relative to skin  marks  caused by CT scan and 
treatment  performed on  different treatment couches 
It is the only one possible part  of overall  systematic setup error. 
RANDOM ERROR: 
It is a deviation that can vary in any direction and magnitude for each delivered 
fraction of treatment.` 
It is classified into individual and population random errors. 
Individual: 
                  It is the standard deviation of the measured errors during the delivery of 
treatment in each fraction. 
Population random error: 
                  It is calculated for  group of patients as the mean of individual random 
errors.It usually occurs at treatment delivery stage and hence called execution 
errors. 
Types of random errors: 
 1.Patient setup error: 
They are  unpredictable changes occurng  from  change in patients 
position.,treatment machine and setup difference between each delivered fraction. 
2.Target  position and shape: 
 It accounts for motion between  the treatments rather than from delineation to 
treatment. 
 
 
3.Intrafraction errors: 
Its the  change in the patient position and internal anatomy arising during delivery 
of single fraction eg:breathing 
 Offline correction strategy may not predict the random error part  in subsequent 
fractions and hence  treatment margins must be calculated to include these 
variations.  
The individual mean set-up error is the mean set-up error for an individual 
throughout the treatment regimen and is calculated as the ratio of the sum of the 
measured set-up errors for each fraction to number of imaged fractions. It can be 
expressed by the formula: 
 
Overall population mean for the analyzed group of patients is a strong indicator of 
any given treatment technique and it should be ideally zero. It is calculated as the 
ratio of sum of the mean errors of the individuals of the group to the number of 
patients in the analyzed group. It can be expressed using the following formula: 
    
Population systematic error is defined as the standard deviation of the individual 
mean set-up errors about the overall population mean. It’s calculated as the square 
root of ratio of the sum of the squares of the differences between the overall 
population mean and individual patient mean to the total number of patients minus 
one. It can be expressed as follows: 
   
The individual random set-up error is a measure of the standard deviation of the 
setup errors around the corresponding mean individual value. It is calculated as 
square root of the ratio of sum of the squares of the differences between the mean 
individual error and the set-up error from each image in turn to the total number of 
images minus one. Mathematically expressed as: 
  
 
Population random setup error is the mean of all the individual random errors. It is 
calculated as the ratio of sum of all the individual random errors to the total 
number of patients assuming that all patients are imaged similar times.  
 
It is mathematically expressed as: 
    
 
 
 
 
 
 
Diagram of the impact of geometrical deviations on  dose distribution: 
 (a) random errors lead to blurring of  dose distribution 
(b) systematic errors lead to shift of the cumulative dose distribution relative 
to  CTV 
                        
  
 
 
 
 
 
 
                     WORKFLOW OF RADIOTHERAPIC CHAIN-STEPS                                   
                                               CHECKED WITH EPID 
 
 
 
Measurement of Geometrical Errors and its Correction: 
Geometrical errors measurement is important for definition of margins. The more 
important one to correct is systematic error because it has more effect on 
magnitude.  
1.Target volume delineation – It is  measured by multi-observer studies and is  
reduced by clear protocols such as RTOG, training and consultation and multi-
modality imaging without relying on single modality image information  .  
2.Organ motion: 
Tumor motion is measured by CT ,markers detected through X ray,EPID.USG and 
CBCT are alsoused recently for tracking of tumor.We can correct this by 
gating,good treatment  and CT scan protocols.The most effective way to reduce 
this is adaptive radiotherapy using daily online imaging for atleast first few 
fractions which helps in achieving smaller systematic errors. 
3.Setup errors: 
Portal imaging helps in reducing setup errors.For this portal image is compared 
with simulation image and matching should be done.Best way is compare DRR 
with portal image.Bony landmarks  kept as guidance and matched with DRR.On 
line and offline review should be done and errors are measured and corrected. 
 
 
 
 
 
 
Random and systematic errors.  
Each group of points represents the fractions of single  patient.  
The scatter within a group is  day-to-day variation.  
The group average (the five larger squares) is the systematic error of a 
patient.  
The mean of all patient averages is indicated by the large yellowish orange 
square and this is the overall mean. 
 
 
 
 
The effect of  setup displacement on the dose distribution relative to 
CTV.Random  deviations leads to a blurring  of the dose 
distribution.systematic deviations lead to shift in the dose distribution relative 
to the CTV. 
If  uncorrected the systematic error remain throughout the course of 
treatment thereby compromising dose coverage to the CTV. 
Verification is needed to ensure that systematic displacement lies within 
tolerance levels. 
Offline review corrects systematic errors during treatment and only 
remaining thing is random error. 
 
HOW TO CREATE GEOMETRIC VERIFICATION PROCESS: 
The verification process  should consider 
1.Personnel,responsibility and training. 
2.Equipment and technical infrastructure. 
3.Imaging protocols 
       -Imaging 
       -Frequency ,time of imaging. 
4.Measurement of setup errors 
     -systematic error 
     -Random error 
5.Action levels,Tolerances and correction strategy. 
6.For concomitant exposure dose measurements should be considered. 
EQUIPMENT AND TECHNICAL INFRASTRUCTURE: 
1.Images should be in good quality and to be able to give information needed. 
2.Effcective connectivity is needed. 
3.Clear conventions are required  for coordinatings system and error reporting. 
4.Good quality assurance . 
5.Uncertainities in verification process should be calculated. 
6.For good complete verification process suitable software must be used. 
 
 PERSONNEL,RESPONSIBILITIES AND TRAINING: 
1.To set guidelines on structure and process a good verification team is requireds . 
2.Assessment of training and competency are required. 
3.For an each institute a risk analysis should be done. 
IMAGING PROTOCOLS: 
1.Image acquisition  depends on quantity of satble anatomy seen within the field. 
2.Timing of image acquisition should be ideal. 
3.Atleast two orthogonal images are required to verify image in all directions. 
4.To assess systematic error for radical treatment atleast three to five imaging sets 
are needed.. 
5.Site and treatment technique decides number of fractions to be imaged. 
MEASUREMENT OF SETUP ERRORS: 
1.Prior to first treatment gross error should be detected. 
2.Individual ssystematic setup error should be calculated and minimized. 
 
SUMMARY,TOLERANCES,ACTION LEVELS AND CORRECTIVE 
STRATEGIES: 
1.Gross errors musts be corrected as  soon as possible. 
2.Radiotherapy department in each institute have to evaluate their tolerances 
3.Tolerances used in imaging protocol depends on  
                      a.Anatomical site 
                      b.The technique of treatment. 
                      c.CTV-PTV margin. 
                      d.At last the compliance of the patient. 
4.What are the action to be taken in treatment verification: 
                      a.Further repeat imaging it was a simple random error. 
                      b.Systematic error reassessment. 
5.Corrective strategies: 
                   a. Needs accurate calculation of systematic  setup error. 
                    b.Then the choosed  correction strategy should be applied to remove   
                      the error. 
                    c.Corrections applied to treatment setup must be verified. 
                    d.Weekly imaging is necessary. 
DOSE CONSIDERATIONS: 
a. Dose accumulation due to concomitant exposures and treatment 
accuracy using  imaged information should be optimized. 
b.It is better to setup and image correctly for ensure adequate and 
accurate coverage of target volume and to avoid risk associated with 
additional exposure. 
  
 
RELATIONSHIP BETWEEN CTV-PTV TREATMENT MARGIN   AND     
                      TREATMENT VERIFICATION  
CTV-PTV margins is influenced by both  systematic and random errors. 
Using online imaging  treatment is verified and quantified to reduce sources 
causing errors and to reduce applied applied margin. 
  
 
  
 
 
APPROPRIATE  PROTOCOL FOR HEAD AND NECK VERIFICATION: 
On fraction 1-Before starting treatments: 
      1.Orthogonal images to be taken to minimize dose to the critical  
        structures. 
      2.Acquire images for all possible treatment fie;ds ifd field edge verification  
         is needed. 
       3.Verify and correct gross errors immediately. 
On fraction 2 and 3 
       To take orthogonal images and  assess each image against tolerance level set  
       and correct gross errors. 
Action before fraction 4 
        1.Calculate systematic error in AP,SI,ML directions. 
        2.If setup error is more than the action level we have to apply systematic setup  
          error correction. 
Fraction 4 and 5 
       If setup is corrected then do repeat imaging. 
       If practical then calculate the new overall systematic setup error and correct  
      values greater than action level. 
 
Weekly and first day of each phase of treatment plan: 
       1.To take orthogonal image each week. 
       2.Correct gross errors for each fraction whenever necessary. 
       3.If setup error significantly differs then do repeat imaging. 
 4.Apply systematic setup error correction if needed.  
 
 
  
 
 
OTHERS: 
*Immobilisation is strictly neccessary. 
*Impact  of organ motion  of tongue and larynx considered. 
*Isocentre should be verified using anterior,posterior and lateral views. 
*Bony anatomy should be clearly taken in the images taken. 
*Tumors planned with very small margins or hypofractionated treatment are daily 
verified with images. 
ANATOMIC STRUCTURES SHOULD BE MATCHED: 
 
 
 
EVIDENCE FOR HEAD AND NECK  TREATMENT  VERIFICATION 
GUIDELINES: 
IMMOBILISATION AND APPROPRIATE SPATIENT POSITIONING: 
  a)Low and high melting point thermoplastic masks. 
  b)Bite blocks. 
Tumor shrinkage and weight loss leads to change in patients anatomy and ill fitting 
immobilization device over the course of treatment. 
GTV decreases by 1.8% if there is large nodal mass at the start of treatment. 
These patients should be considered  for remoulding and replanning  at 3rd or 4th 
week of treatment . 
SETUP REPRODUCIBILITY: 
More effective immobilization produces good setup reproducibility.Moulds should 
not be used immediately after preparing because there is shrinkage of 2mm in the 
first 24 hours. 
If the field covers the lower neck and supraclavicular fossa shoulders should be 
matched exactly where more differences occur. 
4)ANATOMY  
OROPHARYNX: 
Anteriorly-oral cavity. 
Postoinferiorly-larynx and hypopharynx.  
Superiorly -nasopharynx. 
Subsites:Tonsil,Base of tongue,soft palate. 
Tonsil-consists of anterior and posterior  tonsillar pillar between them there is cleft 
where palatine tonsil is located. 
Base of tongue-comprises of posterior 1/3 of tongue 
Borders-Anetrior-circumvallate papillae in front of sulcus terminalis. 
Posterioinferior-hyoid and epiglottis. 
Laterally-glossopharyngeal sulci. 
Lingual tonsil present under base of tongue. 
Vallecula- is a 1 cm mucosal strip between base of tongue and epiglottis. 
Sensory innervation of the base of tongue is glossopharyngeal nerve. 
Soft palate-fibromuscular structure  
Boundaries: 
Anterior-hard palate. 
Lateral-anterior tonsilar pillar 
Midline-uvula. 
Posteroinferior-free edge. 
Components of soft palate-levator veli palatini, 
palatoglossus,palatopharyngeus,musculus uvulae. 
Muscles of soft palate supplied by pharyngeal plexus. 
Lymphatic spread: 
Most common-ipsilateral level II. 
Order of metastatic progression: 
Level I/II superiorly                    midcervical(level III)                lower 
cervical(levelV) inferiorly.. 
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HYPOPHARYNX  
Behind the Larynx (in front of 3rd to 6th Cervical vertebra) From the tip of 
epiglottis superiorly to the lower border of cricoid cartilage inferiorly 
Communicates: - Anteriorly with the Larynx ,Superiorly with the oropharynx 
Inferiorly with the esophagus 
 
 The hypopharynx does not only lie behind the larynx but also Projects laterally on 
each side of the larynx So it is formed of : Postcricoid region ( behind the larynx) - 
Two pyriform fossae and posterior pharyngeal wall. 
PYRIFORM SINUS  
Shape : inverted pyramid.  
Extent: -Superiorly: epiglottis .  
Lateral: thyroid cartilage  
Medial: arytenoid cartilage; aryepiglottic fold.  
Posteriorly: open & continuous with posterior pharyngeal wall.  
Apex: meeting of anterior, lateral &medial wall inferiorly 
POST CRICOID REGION  
Pharynx mucosa covering post. Surface of cricoid  
Pharynx become continuous with esophagus at post cricoid region  
Extent:  
Superior: arytenoids  
Inferior: oesophagus  
POSTERIOR PHARYNGEAL WALL  
Cover middle & inferior constrictor muscles.  
Separated from prevertebral fascia by retropharyngeal space.  
Extent: Superiorly: upper border of epiglottis  
Inferior: lower border of cricoid  
Sideways: apex of one pyriform sinus to other. 
Nerve supply of hypopharynx  
Internal branch of superior Laryngeal nerve :vagus(X) 
Glossopharyngeal nerve :(IX)  
sensory: External branch of superior Laryngeal nerve (X) Recurrent laryngeal 
nerve (X) Pharyngeal plexus (IX) motor 
LYMPHATIC DRAINAGE  
Deep cervical lymph node : level 2,3& 4  
Prelaryngeal & paratracheal lymph nodes: level 6.  
Retropharyngeal node -Node of rounviere at skull base. 
POST CRICOID AREA: The hypopharynx leading to upper oesopageal 
sphincter. Occasionally brisk opening seen apon laryngeal examination . Upper 
osophageal sphincter opening- upon rigid oesophagoscopy. 
CARCINOMA HYPOPHARYNX  
Constitute 5.2% of upper aerodigestive tract cancer.  
Mostly squamous cell carcinoma of hypopharynx.  
Mean age of presentation 65 years  
Common stage of presentation : stage III& IV -POOR PROGNOSIS 
INCIDENCE OF HYPOPHARYNX CARCINOMA.  
65-75%-pyriform sinus carcinoma 
5-15% - post cricoid carcinoma. 
10-20% -posterior pharyngeal carcinoma. 
RISK FACTORS OF CARCINOMA HYPOPHARYNX  
Age & Sex: carcinoma pyriform fossa- male above 40 years  
Carcinoma postcricoid region: females 20 to 40 years  
Carcinoma posterior pharungeal wall : males above 50 years  
Family history -Tobacco ,Alcohol  
Exposure : polyaromatic compounds ; asbestos & welding fumes  
Nutritional deficiency. VIT A & E. iron, Carotenoids and flavenoids. 
RISK FACTORS OF CARCINOMA HYPOPHARYNX  
infections; HPV (20–25% only postive for HPV DNA & Ab against HPV 16 E6 & 
E7)  
Associated diseases: PLUMMER VINSON SYNDROME  
GENETIC: P53 & EGFR mutation -Synchronous & metachronous malignancy. 
FIELD CANCERIZATION  
Hypopharynx Carcinoma occur within field of diseased mucosa .Carcinogens 
induce dysplastic changes in mucosa of the upper aero digestive tract. Increased 
risk of malignancy 
CARCINOMA OF PYRIFORM SINUS  
Age:40 years  
presentation: late; Metastatic neck nodes  
Spread: local Upwards: base of tongue Downwards: post cricoid region Medially: 
AE fold and ventricle Laterally: thyroid cartilage, -Lymphatic spread: upper and 
middle group of jugular cervical nodes -Distant metastasis: occur late and may be 
seen in lung, liver, bone 
 
CARCINOMA OF POST CRICOID REGION  
Plummer-Vinson syndrome age group of 20-40; female Progressive dysphagia 
Voice change Weight loss  
Spread: local spread - cervical oesophagus, arytenoids  
Lymphatic spread - paratracheal nodes, may be bilateral due to midline nature of 
lesion 
 
CARCINOMA OF POSTERIOR PHARYNGEAL WALL  
Mostly seen in males above 50 years of age  
Clinical features: dysphagia, metastatic neck node  
Spread: local - prevertebral fascia, muscles and vertebrae  
Lymphatic: usually bilateral, retropharyngeal and deep cervical nodes involved 
CLINICAL PRESENTATION  
Hoarseness of voice: vocal cord fixation  
Stridor: mass effect on trachea  
Weight loss. Anemia, malnutrition, Throat pain, Sore throat dysphagia 
Odynophagia ,pooling of saliva  
Referred otalgia: cause int. laryngeal nerve (X) Neck mass: metastatic neck node 
Direct extension most frequent presenting symptoms include a neck mass (either 
representing the tumour or nodal metastases . 
 
 
                          
                            
 
 
 
                               ANATOMY OF HYPOPHARYNX 
           
                STAGING OF HYPOPHARYNGEAL CANCER: 
             
CLINICAL EVALUATION  
History taking  
General physical examination  
Oral hygeine & dentition  
Airway status  
Status of speech & swallow.  
Complete examination of oral cavity , oropharynx.  
Examinaton of neck nodes.  
Indirect layngoscopy  
Direct laryngoscopy 
EXAMINATION OF NECK NODES  
Location ,Size ,number ,Mobility ,Tenderness ,Relationship with adjacent 
structure. 
Examination of neck nodes: sub mental(Ia) & submandibular(Ib) 
Examination of neck nodes: upper.,middle & lower deep cervical (ii; iii. iv) 
INDIRECT LARYNGOSCOPY -mirror warmed; check temp. -Hold tongue -
Introduce mirror into the oral cavity facing downwards - mirror brought to rest 
against the uvula -do not touch the posterior pharyngeal wall - laryngeal inlet is 
visualized, 
Structures seen on indirect laryngoscopy (in order):  
Base of the tongue ,Vallecula ,Median and lateral glossoepiglottic folds 
Epiglottis ,Vestibular fold ,True vocal cords ,Trachea ,Layngeal cartilage 
 
PRE TREATMENT EVALUATION:  
To asses extent of tumor Relation with other structure Involvement of larynx 
Mobility of vocal cords  
Direct laryngoscopy  
Oesophagoscopy  
Bronchoscopy  
Panendoscopy  
Chest x ray :infection; malignancy;metastasis  
HRCT : thickness, invasion, L.N metastasis  
MRI :soft tissue details, tissue edema  
PET :residual or recurrent tumor after RT 
 
NASOPHARYNX: 
It is a cuboidal chamber. 
Boundaries: 
Anteriorly:continuous with nasal cavity via posterior choanae. 
Inferiorly-oropharynx. 
Roof-basilar portion of sphenoid and occipital bones. 
Floor-superior surface of soft palate and nasopharyngeal isthmus. 
Lateral- Eustachian tube 
Lateral wall contains fossa of rosenmuller –most common origin of malignancy. 
Nerve supply-sensory-maxillary division of trigeminal nerve and glossopharyngeal 
nerve. 
Motor-glossopharyngeal nerve,vagus nerve and sympathetic fibres from superior 
cervical ganglion. 
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REVIEW OF LITERATURE: 
  
BMF such as body weight, body height, and the circumference and bilateral 
thickness of the neck of patients were taken from the online Kilo-voltage CBCT 
acquired using the on-board imager and assessment of setup errors by systematic 
error (SE) and random error (RE) through the superior-inferior (SI), anterior-
posterior (AP), and medial-lateral (ML) directions, and couch rotation (CR).  The 
magnitude of the effect of BMF could be calculated using Mann–Whitney U test. 
Among the ratios of the BMFs during radiotherapy, the values at the level of 
mastoid tip at the 20th fraction were associated with greater setup errors. 
Deviation between intended geometry of radiotherapy plan and real geometry of 
radiotherapy treatment were presented as geometrical errors.Buildup of smaller 
errors, which can be generally classified as set-up, organ motion, organ 
delineation, and technical condition related errors is the total geometrical error. 
The amount of systematic and random component of these errors should be 
encountered in treatment planning process and a clear distinction must be made 
between them. The amount of most of geometrical errors can be predicted, 
minimized, and kept under control if errors are measured with EPID and proper 
correction strategy are deployed; the precision of treatment and consequent results 
can also be improved. 
IMRT treatments are more sensitive to setup errors and so taking into account the 
systematic errors in treatment plans. A planning margin to account for set-up errors 
was added to the clinical target volumes and to the spinal cords and the part of the 
target covered with a dose >95 and <105% and the effect in the critical organs is 
dependent on the sharpness of the dose gradients outside the critical organ thereby 
it is plan quality dependent too. 
The setup displacements and translational and rotational errors were taken into 
account from the online images acquired prior to treatment and based on that 
individualized margins for CTV, PTV was generated. 
 
 
II)OBJECTIVE AND METHODOLOGY: 
1)AIM OF THE STUDY: 
To analyse the impact of body mass factors before radiotherapy and changes 
occurring during radiation leading to setup displacement in patient with head and 
neck cancers and need of replanning. 
2)OBJECTIVE 
Primary objective: 
By assessing degree of setup error and effects of Body Mass Factors on setup 
errors  we can analyse the need of replanning and to assess whether these factors 
are really helpful in replanning and Adaptive radiotherapy . 
Secondary objective: 
1.TCP/NTCP ratio calculation . 
2.Change in Body mass factors and need of replanning. 
3.Impact of replanning 
Sample size: 50. 
Study design:Prospective  
Study period: December 2014-October 2015. 
Inclusion criteria:  
All patients with 
1. Age >30 years. 
2. Both sexes 
3. Sites included-Nasopharynx,oropharynx,hypopharynx. 
4. Patients planned for definitive Chemoradiation/definitive radiation. 
5. ECOG performance status-0-2 
6. Informed consent from patient. 
 
Exclusion criteria: 
1. Patients with poor performance status. 
2. Patients initially treated outside. 
3. Patients who had initial surgery. 
4. Patients with palliative intent treatment. 
 
 
3)Methods and Materials:   
Methods of Planning: 
1.Patients are immobilised with thermoplastic mask. 
2.CT for RT planning done from Orbit to shoulder with 3mm cuts 
3.Marks like leadshot are placed over patients surface using laser to facilitate 
accurate  daily position.  
4.For patients receiving definitive radiation CTV was defined as GTV+1-1.5cm 
margin.Guidelines for delineation of elective nodal CTV were followed.PTV was 
extended 3mm around CTV. 
5.IMRT plans are generated. 
6.Prescription dose will be 54 Gy to CTV and boost to high risk regions primary 
and involved lymph nodes  of about  Total dose 66 Gy. 
Method of Treatment verification: 
1.Patients are postioned on the couch according to reference marks already kept 
during planning. 
2.Online On board imaging (2D KVCT daily and 3D CBCT at 10 th and 20 th 
fraction )were taken and registered with Digitally reconstructed radiographs from 
the treatment planning images. 
3.Images are compared by correlation of bony anatomy and differences are 
corrected by shifting couch translationally before treatment. 
4.Atleast 3 reference landmarks included-3 visible bony landmarks: 
1.Vertebra of Cervical Spine.2.Nasal septum.3.Mandible profile. 
Anthropometric Measurements of Body related Factors: 
Patient related Factors: 
1.Performance score. 
2.Age 
3.Body mass factors. 
4.Performance status:Scored according to ECOG. 
5.Body mass factors included are a)BMI b)Circumference and  thickness across 
three specified sections of head and neck. 
Level A-Line drawn at level ofMastoid tip ,same section as the junction between 
skull base and 1 st cervical vertebra. 
Level B –Line drawn based on mandible angle,same height as the junction between 
2nd and 3 rd cervical vertebra. 
Level C-Line drawn at  level of  thyroid notch ,same as the 5 th cervical vertebra. 
 
 
 
 
 
                        
                               
                       Level A 
                       Level B 
                       Level   C 
3.Body mass factors will be recorded before RT and at 10th and 20 th fractions 
during course of radiation. 
4.Circumference and thickness values are retrieved from CT simulation images and 
Cone beam CT images at three specified levels during treatment. 
5.Circumferences are calculated by brushing body contour at specified section with 
fixed thickness to generate volume,and then calculated volumes are divided by the 
contouring thickness to get the values of circumferences. 
6.Thickness is calculated as the maximal transverse distance at same distance as 
circumferences. 
7.Body mass index  was calculated by dividing weight in kilograms  by height in 
metre square. 
8.Patients are monitored weekly and toxicities are recorded according to CTCAE. 
9.Ratio of BMFs during RT are calculated at three levels. 
Ratio of Circumference at n th fraction =  
                          Cirumference at level A at n th fraction      Pretreatment 
                                                                                               Circumference 
 
Patient characteristics before radiotherapy 
Number Variable Values 
1. Age(years) 
Median 
 
54 years 
2. Weight(kg) 
Mean 
Median 
 
56.5 years 
54 years 
 
3 Height(cm) 
Mean(range) 
Median 
 
164.4 cm 
165 cm 
4 BMI 
Mean(range) 
Median 
 
23.2 
22.8 
5 ECOG PS 
0 
1-2 
 
24 
26 
6 CCRT/RT alone 
CCRT 
RT alone 
 
 
41 
9 
7 Tumor site 
Oropharynx 
Hypopharynx 
nasopharynx 
 
18 
29 
3 
8 Circumference A(cm) 
Mean ±SD 
 
48±2.6 
 
9 Thickness A 
Mean ±SD 
 
15.1±1.2 
10 Circumference B(cm) 
Mean ±SD 
 
42±2.8 
11 Thickness B(cm) 
Mean ±SD 
 
13.2±1.4 
12 Circumference C(cm) 
Mean ±SD 
 
37±4.2 
13 Thickness C(cm) 
Mean ±SD 
 
11.5±1.6 
 
 
 
Set Up Displacement: 
Daily on board image taken and an offline image review should be done and setup 
errors are calculated in Anteroposterior,mediolateral,Superoinferior directions.s 
For each direction systematic and random errors calculated. 
Systematic error was the deviation between simulated patient position and average 
treatment  position.Random error occurs between different fractions.By analysing 
all the alignment data before 25 fractions of treatment for every  patient ,values of 
systematic and random errors for all AP,SI.ML directions are calculated.  
Stastical Analysis: 
1.To determine the correlation between magnitude of errors and patient related 
factors  are classified into two groups and  .calculated using Mann-whitney U test. 
2.To examine association between the reduction ratio of body weight and 
circumferences or thickness,displacement in different direction Pearson correlation 
coefficient is used. 
AP-ANTEROPOSTERIOR             ML-MEDIOLATERAL 
SI-SUPEROINFERIOR                   SE-SYSTEMATIC SRROR 
RE-RANDOM ERROR.                  CR-COUCH ROTATION   
Setup Errors (mean ± standard deviation in mm) in AP,SI,ML directions 
according to low range and high range 50% percentile of body mass 
factors before RT 
 
 
variable AP-SE AP-RE SI-SE SI-RE ML-SE ML-RE 
Weight 
Lower 
Higher 
P value 
 
0.8±0.4 
1.2±0.5 
0.045* 
 
0.8±0.2 
0.8±0.2 
0.250 
 
2±0.8 
2.3±0.9 
0.556 
 
1.1±0.3 
1.7±0.8 
0.022* 
 
1.7±0.7 
1.8±0.5 
0.426 
 
1±0.2 
0.9±0.3 
0.450 
Height 
Lower 
Higher 
P value 
 
1±0.5 
1.2±0.7 
0.07 
 
0.7±0.3 
0.8±0.3 
0.15 
 
1.8±0.5 
2.5±1 
0.106 
 
 
1±0.2 
1.8±0.8 
0.002* 
 
1.7±0.6 
1.8±0.6 
0.26 
 
1±0.3 
1±0.3 
0.82 
BMI 
Lower 
Higher 
P value 
 
1±0.4 
1.2±0.7 
0.17 
 
0.7±0.3 
0.8±0.3 
0.506 
 
2.1±0.9 
2.1±1 
0.924 
 
1.3±0.5 
1.5±0.7 
0.208 
 
1.6±0.7 
1.9±0.5 
0.304 
 
1±0.3 
1±0.3 
0.924 
Setup Errors (mean ± standard deviation in mm) in AP,SI,ML directions 
according to low range and high range 50% percentile of body mass 
factors before RT 
Variable AP-SE AP-RE SI-SE SI-RE ML-SE ML-RE 
Circumference –A 
Lower 
Higher 
P value 
 
 1±0.4 
1.2±0.6 
0.335 
 
 0.7±0.3 
0.8±0.3 
0.485 
 
2±1 
2.3±1 
0.304 
 
1.3±0.7 
1.5±0.8 
0.186 
 
1.6±0.8 
2±0.5 
0.344 
 
1±0.4 
1±0.3 
0.411 
Circumference –B 
Lower 
Higher 
P value 
 
1±0.5 
1.2±0.6 
0.388 
 
0.7±0.3 
0.8±0.3 
0.485 
 
2±1 
2.3±1 
0.304 
 
1.3±0.7 
1.5±0.8 
0.186 
 
1.6±0.8 
2±0.5 
0.344 
 
1±0.4 
1±0.3 
0.411 
Circumference-C 
Lower 
Higher 
P value 
 
1±0.5 
1.2±0.6 
0.47 
 
0.8±0.3 
0.8±0.3 
0.566 
 
2.2±1 
2.1±0.7 
0.967 
 
1.3±0.7 
1.6±0.7 
0.334 
 
1.7±0.7 
2±0.5 
0.240 
 
1±0.3 
1.1±0.3 
0.672 
PS 
0 
1-2 
P value 
 
0.9±0.4 
1.4±0.5 
0.042* 
 
0.7±0.3 
1±0.3 
0.015* 
 
2±0.9 
2.5±1.1 
0.24 
 
1.2±0.3 
1.8±1 
0.042* 
 
2±0.6 
1.6±0.7 
0.071* 
 
1.1±0.3 
1±0.4 
0.933 
  
 
 Setup Error (mean ± standard deviation in mm) in AP,SI,ML directions according 
to low range  and high range  50% percentile of body mass factors during RT (10th 
fraction) 
 
VARIABLE AP-SE AP-RE SI-RE SI-RE ML-SE ML-RE 
rT(level A) 
lower<0.98 
higher>0.98 
P value 
 
1±0.5 
1.2±0.5 
0.184 
 
0.8±0.3 
0.9±0.4 
0.283 
 
2.3±1.1 
2±0.8 
0.843 
 
1.6±0.8 
1.3±0.7 
0.421 
 
2±0.5 
1.6±0.6 
0.223 
 
1.1±0.4 
1±0.3 
0.043* 
rT(level B) 
lower<0.97 
higher>0.97 
P value 
 
1±0.5 
1.1±0.7 
0.665 
 
0.8±0.2 
0.9±0.3 
0.917 
 
2.1±1 
2.2±0.9 
0.462 
 
1.3±0.4 
1.5±1 
0.447 
 
1.7±0.7 
1.9±0.6 
0.324 
 
1.2±0.3 
0.9±0.25 
0.018* 
rBW 
lower<0.99 
higher>0.99 
P value 
 
1.1±0.5 
1.1±0.5 
0.842 
 
0.9±0.3 
0.9±0.3 
0.873 
 
2±0.7 
2.1±1.1 
0.808 
 
1.4±0.4 
1.4±0.8 
0.883 
 
2±0.7 
1.7±0.5 
0.778 
 
1.1±0.3 
1±0.3 
0.256 
 
rT-ratio of thickness. 
Bw-Body weight. 
rC-ratio of circumference 
  
        Association between ratio of weight and thickness at level A during 
                               the 20th fraction of CBCT (r = 0.32, p = 0.081).
 
 
 
 
 
  
Setup Error (mean ± standard deviation in mm) in AP,SI,ML directions according 
to lower and higher 50% percentile of body mass factors during RT  
 (20th fraction) 
  
 
Variable AP-SE AP-RE SI-SE SI-RE ML-SE ML-RE 
rC(level A) 
lower 
higher 
P value 
 
1.3±0.5 
0.8±0.5 
0.018* 
 
1±0.2 
0.7±0.3 
0.018* 
 
2.4±0.9 
2±1 
0.094 
 
1.8±0.8 
1.2±0.4 
0.025* 
 
1.6±0.7 
2±0.5 
0.100 
 
1±0.3 
1±0.4 
0.852 
rT(level A) 
Lower 
Higher 
P value 
 
1.2±0.6 
 
1±0.4 
 
0.324 
 
0.9±0.3 
0.8±0.3 
0.324 
 
2.4±1.3 
2±0.5 
0.460 
 
1.6±0.7 
1.2±0.7 
0.050 
 
2.1±0.6 
1.5±0.6 
0.013 
 
1.1±0.3 
1±0.3 
0.216 
rBW 
Lower 
Higher 
P value 
 
1.2±0.4 
1±0.7 
0.376 
 
0.9±0.3 
0.9±0.4 
0.607 
 
2.4±1 
2±0.9 
0.182 
 
1.5±0.5 
1.5±0.9 
0.323 
 
1.8±0.7 
1.9±0.6 
0.78 
 
1.1±0.3 
1±0.2 
0.607 
Replanning  
Replanning CT done at 40 Gy for all patients.Old plan applied to the replanning 
CT and difference in NTCP/TCP ratio calculated and correlation between the Body 
mass factors ,setup errors are analysed  . 
    CT SCAN OF THE PATIENT WITH OROPHARYNGEAL CANCER   
                               SHOWING GOOD REGRESSION: 
 
NTCP AND TCP COMPARISION: 
If the patient has large reduction ratio in  circumference of (<1) and thickness of 
(<0.94) at  the level of the mastoid tip on the 20th fraction of treatment and larger 
body weight or height and a performance score of 1-2.Replanning   
has showed significant reduction in normal tissue complication probability when 
compared to patients who had no difference actuall 
 NTCP Patients with difference in 
BMFs and Setup errors 
Patients without difference in 
BMFs and Setup errors 
CORD (Mean %) 0.0000001909 % 0.0000026804% 
BRAIN STEM(Mean %) 0.0000181882 % 0.0002341159% 
III) RESULTS AND ANALYSIS: 
DIRECTION MEAN 
DISPLACEMENT IN 
mm 
POPULATION 
SYSTEMATIC 
ERROR IN  mm 
CTV-PTV 
MARGINS 
SUGGESTED 
SUPEROINFERIOR 1.4 2.1 3.3 
ANTEROPOSTERIOR 1.5 1 4.6 
MEDIOLATERAL 2.1 1.5 6.5 
 
                   
     
COUCH ROTATION POPULATION 
SYSTEMATIC ERROR 
POPULATION 
RANDOM ERROR 
DEGREES 0.30 0.34 
CORRELATION  BETWEEEN  COUCH  ROTATION AND ERRORS  
                                 IN OTHER DIRECTIONS 
DIRECTION SYSTEMATIC ERROR RANDOM ERROR 
ANTEROPOSTERIOR NO CORRELATION NO CORRELATION 
SUPEROINFERIOR NO CORRELATION NO CORRELATION 
MEDIOLATERAL P=0.008 P=0.015 
 
#CORRELATION BETWEEN THICKNESS AT LEVEL A AND BODY 
WEIGHT RATIO-NOT  SIGNIFICANT(FROM CBCT AT 20 TH FRACTION) 
 
 
CORRELATION BETWEEN RATIO OF WEIGHT AND 
CIRCUMFERENCE  AT 10 TH OR 20 TH FRACTION AT ALL THREE 
LEVELS. 
 
LEVELS  10 TH FRACTION 20 TH FRACTION 
LEVEL A NO CORRELATION NO CORRELATION 
LEVEL B NO CORRELATION NO CORRELATION 
LEVEL C NO CORRELATION NO CORRELATION 
 
CORRELATION  BETWEEN  PRETREATMENT  BMFs  AND  SETUP  
                                                      ERRORS: 
FACTORS AP-SE AP-RE SI-
SE 
SI-RE ML-
SE 
ML-
RE 
CR-SE CR-RE 
LARGE 
WEIGHT 
P=0.045* NS NS P=0.023* NS NS NS NS 
LONG 
HEIGHT 
NS NS NS P=0.002* NS NS P=0.033* P=0.067 
PS 1 OR 2 P=0.042* P=0.015* NS NS NS NS NS NS 
AGE NS NS NS NS NS NS NS NS 
BMI NS NS NS NS NS NS NS NS 
ASSOCIATION BETWEEN BMFs DURING RT(10TH FRACTION) 
BMFs AP-SE AP-RE ML-SE ML-RE SI-SE SI-RE 
THICKNESS 
LEVEL A 
NS NS NS P=0.043* NS NS 
THICKNESS 
LEVEL B 
NS NS NS P=0.018* NS NS 
 
 
ASSOCIATION BETWEEN BMFs DURING RT(20TH FRACTION) 
BMFs AP-SE AP-RE ML-SE ML-RE SI-SE SI-RE 
rC 
LEVEL A 
P=0.018* P=0.018* NS NS P=0.025* NS 
THICKNESS 
LEVEL B 
NS NS P=0.013* NS NS P=0.05* 
 
CORRELATION BETWEEN  THICKNESS AT LEVEL A AND COUCH 
ROTATION(20TH FRACTION) 
FRACTION CR-SE CR-RE 
10TH 
 
NS NS 
20TH  P=O.OO9* P=O.O19* 
 
*-SIGNIFICANT 
NS-NOT SIGNIFICANT. 
 
 
#At 10 th fraction  thickness at level C and ratio of Circumference at  level A,B 
and C had no effect on setup errors. 
#At 20th fraction,ratio of circumference at level B,C had  thickness at level B,C had 
no significant correlation between errors. 
IV)DISCUSSION: 
Setup uncertainty may change dose distribution to target volume and OARs in 
head and neck cancers. To overcome this image guided radiotherapy and adaptive 
radiotherapy are used. According to the ICRU 62, inappropriate CTV-PTV margin 
leading to setup displacement and organ motion leads to underdose of CTV. To 
define this margin for Head and neck cancer, variability due to setup uncertainties 
must be corrected and organ motion may be neglected. But in practical scenario, 
extensive imaging for daily IGRT is not always feasible.  
Based on these results patients with large body weight, height, and PS of 1 or 
above, can be selected for daily online imaging and adaptive radiotherapy.  
CTV to PTV margins should be altered relevantly in all directions if IGRT is not 
possible. Head and Neck cancer patients receiving RT exhibit significant 
anatomical changes due to tumor regression after the delivery of therapeutic dose. 
The geometric change of the target and OARs should be assessed with the help of 
on-line images acquired during the treatment regimen. Patients having unfit 
immobilizations are usually considered for ART. But the correct guidelines for 
adaptive radiotherapy are still lacking. Albeit the increase in the quality of life of 
the patients undergoing ART, it also increases the workload of the staff and the 
cost of the treatment to the patients. This study was done mainly to determine the 
effect of Body mass factors before and during radiation on positioning 
displacement for patients treated with Head and neck cancers and to correlate 
between Body Mass Factors and the extent of daily setup errors. These  results 
helps us to  ascertain who should be regarded for on-line image guided 
radiotherapy before starting RT, and determine those who really require ART to 
decrease setup error. 
V) CONCLUSION: 
Head and neck cancer patients with large body weight or height, and performance 
status score of 1–2 receiving radiation either with or without chemotherapy are 
recommended to be done daily online imaging. Patients exhibiting a large 
reduction ratio in circumference (<1) and thickness (<0.94) on the 20th fraction of 
the treatment at the level of the mastoid  tip can be considered for Adaptive 
planning. 
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